NCT06691997

Brief Summary

The incidence of DM is unclear in RA but most prior data suggest that DM or insulin resistance in RA has risen because of activation of the immune system and/or RA therapy . Besides, RA causes joints to become stiff, swollen, and agonizing. As a result, the patient may not want to exercise or move. One study found that 42% of people with RA are not physically active. the aim of this study is To evaluate the glycemic status among RA patients with Type 2 diabetes and its association with disease activity.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
13mo left

Started Dec 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Dec 2024Jun 2027

First Submitted

Initial submission to the registry

October 27, 2024

Completed
22 days until next milestone

First Posted

Study publicly available on registry

November 18, 2024

Completed
24 days until next milestone

Study Start

First participant enrolled

December 12, 2024

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 14, 2026

Expected
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2027

Last Updated

November 18, 2024

Status Verified

November 1, 2024

Enrollment Period

1.9 years

First QC Date

October 27, 2024

Last Update Submit

November 14, 2024

Conditions

Keywords

glycemic control

Outcome Measures

Primary Outcomes (1)

  • Fasting blood glucose

    correlation between type 2 diabetes control and rheumatoid arthritis activity

    baseline

Study Arms (1)

group 1

RA patients with Type 2 diabetes

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients above age of 18 years old diagnosed with Rheumatoid Arthritis and DM

You may qualify if:

  • type 2 diabetic patients
  • rheumatoid arthritis patients

You may not qualify if:

  • gestional diabetes
  • type 1 diabetic patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Assiut university

Asyut, Egypt

Location

Related Links

MeSH Terms

Conditions

Arthritis, RheumatoidDiabetes Mellitus

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Officials

  • Ahmed khedr Nady

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Eman Mohamed Ibrahim, Lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecture

Study Record Dates

First Submitted

October 27, 2024

First Posted

November 18, 2024

Study Start

December 12, 2024

Primary Completion (Estimated)

November 14, 2026

Study Completion (Estimated)

June 1, 2027

Last Updated

November 18, 2024

Record last verified: 2024-11

Locations